Thermo Fisher Scientific (NYSE:TMO) Shares Gap Down to $271.93

Thermo Fisher Scientific Inc. (NYSE:TMO)’s stock price gapped down before the market opened on Wednesday . The stock had previously closed at $261.75, but opened at $271.93. Thermo Fisher Scientific shares last traded at $276.51, with a volume of 1,750,634 shares traded.

A number of analysts have issued reports on the stock. Zacks Investment Research upgraded shares of Thermo Fisher Scientific from a “hold” rating to a “buy” rating and set a $299.00 price target on the stock in a research note on Wednesday, June 12th. Credit Suisse Group reiterated a “buy” rating and set a $310.00 price target on shares of Thermo Fisher Scientific in a research note on Wednesday, July 31st. Barclays set a $330.00 price target on shares of Thermo Fisher Scientific and gave the stock a “buy” rating in a research note on Monday, July 15th. ValuEngine lowered shares of Thermo Fisher Scientific from a “buy” rating to a “hold” rating in a research note on Wednesday, October 2nd. Finally, Needham & Company LLC upped their target price on shares of Thermo Fisher Scientific from $315.00 to $321.00 and gave the stock a “buy” rating in a research note on Thursday, July 25th. Two research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the stock. Thermo Fisher Scientific currently has an average rating of “Buy” and a consensus price target of $303.17.

The stock’s 50 day moving average is $287.02 and its two-hundred day moving average is $280.65. The company has a debt-to-equity ratio of 0.58, a current ratio of 1.49 and a quick ratio of 1.07. The stock has a market capitalization of $111.60 billion, a PE ratio of 24.87, a price-to-earnings-growth ratio of 1.91 and a beta of 1.13.



Thermo Fisher Scientific (NYSE:TMO) last released its earnings results on Wednesday, July 24th. The medical research company reported $3.04 earnings per share for the quarter, topping the Zacks’ consensus estimate of $3.01 by $0.03. Thermo Fisher Scientific had a net margin of 14.24% and a return on equity of 17.11%. The firm had revenue of $6.32 billion for the quarter, compared to analyst estimates of $6.31 billion. During the same period in the prior year, the firm earned $2.75 earnings per share. The business’s quarterly revenue was up 3.9% compared to the same quarter last year. On average, equities analysts predict that Thermo Fisher Scientific Inc. will post 12.25 earnings per share for the current year.

The company also recently announced a quarterly dividend, which will be paid on Tuesday, October 15th. Investors of record on Tuesday, September 17th will be paid a dividend of $0.19 per share. The ex-dividend date is Monday, September 16th. This represents a $0.76 dividend on an annualized basis and a dividend yield of 0.27%. Thermo Fisher Scientific’s payout ratio is 6.83%.

In related news, CEO Marc N. Casper sold 50,000 shares of the company’s stock in a transaction that occurred on Tuesday, July 30th. The shares were sold at an average price of $284.83, for a total transaction of $14,241,500.00. Following the sale, the chief executive officer now directly owns 342,193 shares in the company, valued at $97,466,832.19. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Marc N. Casper sold 2,271 shares of the company’s stock in a transaction that occurred on Friday, September 13th. The shares were sold at an average price of $298.00, for a total value of $676,758.00. Following the completion of the transaction, the chief executive officer now directly owns 283,502 shares of the company’s stock, valued at $84,483,596. The disclosure for this sale can be found here. Insiders have sold 54,104 shares of company stock worth $15,418,539 over the last 90 days. Insiders own 0.45% of the company’s stock.

A number of institutional investors and hedge funds have recently made changes to their positions in the stock. Pennsylvania Trust Co boosted its holdings in Thermo Fisher Scientific by 9.1% in the third quarter. Pennsylvania Trust Co now owns 65,215 shares of the medical research company’s stock valued at $18,995,000 after purchasing an additional 5,438 shares in the last quarter. Arden Trust Co boosted its holdings in Thermo Fisher Scientific by 6.0% in the third quarter. Arden Trust Co now owns 4,086 shares of the medical research company’s stock valued at $1,190,000 after purchasing an additional 231 shares in the last quarter. Douglass Winthrop Advisors LLC boosted its holdings in Thermo Fisher Scientific by 8.6% in the third quarter. Douglass Winthrop Advisors LLC now owns 7,858 shares of the medical research company’s stock valued at $2,289,000 after purchasing an additional 619 shares in the last quarter. TIAA FSB boosted its holdings in Thermo Fisher Scientific by 1.7% in the third quarter. TIAA FSB now owns 129,373 shares of the medical research company’s stock valued at $37,682,000 after purchasing an additional 2,107 shares in the last quarter. Finally, Gulf International Bank UK Ltd boosted its holdings in Thermo Fisher Scientific by 1.8% in the third quarter. Gulf International Bank UK Ltd now owns 95,262 shares of the medical research company’s stock valued at $27,746,000 after purchasing an additional 1,725 shares in the last quarter. 88.18% of the stock is owned by hedge funds and other institutional investors.

Thermo Fisher Scientific Company Profile (NYSE:TMO)

Thermo Fisher Scientific Inc provides analytical and other instruments, laboratory equipment, software, consumables, reagents, instrument systems, chemicals, supplies, and services under the Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, and Unity Lab Services brands worldwide.

Read More: What is the Difference Between Common Shares and Convertible Shares?

Receive News & Ratings for Thermo Fisher Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific and related companies with MarketBeat.com's FREE daily email newsletter.